comprehensive -WSS

comprehensive

author：knowledge 2025-10-01 14:20:00 - browse：519

Photograph of Bill Cassidy. -- health policy coverage from STAT — Sen. Bill Cassidy (R-La.) Kevin Dietsch/Getty Images

WASHINGTON — With Novo Nordisk’s Wegovy and Ozempic hitting blockbuster sales and a new rival approved this week, everyone in Washington is thinking about how to manage the crashing wave of weight loss drug costs.

The explosive national demand for weight management therapies and diabetes drugs like Ozempic — all of which are indicated for indefinite use — has become central in an ongoing policy debate over high drug costs and controversial tactics to manage them, including President Biden’s plan to let the government negotiate directly with pharmaceutical companies. Seventy percent of Americans could qualify for these medicines.

Sen. Bill Cassidy (R-La.), the highest-ranking Republican on the Senate’s health policy committee, has vehemently opposed the negotiation plan, arguing it reduces incentives to develop new therapies and may not actually reduce patients’ costs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： After affirmative action ruling, medical educators look to 'holistic review'
Next article： Senate committee scrutinizes Medicare Advantage brokers

WSS

A clever new way to fix Medicaid and graduate medical education

Beam Therapeutics to lay off 20% of its staff, re

HPV cancer vaccine study demonstrates efficacy

Biotech incubator Curie.Bio graduates its first startup

Will General Catalyst be the first of many hospital takeovers?

Impact of Dobbs ruling felt at reproductive medicine meeting

Wikipedia

comprehensive

focus

Malaria cases in Florida and Texas: Here’s what you need to know

STAT Summit: GSK CEO on pharma giant's new direction

Medical records are filled with copy

Ambulance rides for just $100? Advisers want major billing fixes

Dobbs anniversary: the lost opportunity of abortion as health care

First Opinion Podcast: Long Covid needs a new approach

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Diversify hospital leadership teams to protect BIPOC patient health

Medical leaders decry Supreme Court decision on affirmative action

Will General Catalyst be the first of many hospital takeovers?

focus

Abortion clinic in Cancun will cater to Americans

STAT Executive Editor Rick Berke on STAT's 8th birthday

FDA approves potent Eli Lilly obesity drug, Zepbound

Pharmacists can make shortage drugs, but at what cost?

FDA struggles to regulate food additives, sometimes for decades

Pharmacists can make shortage drugs, but at what cost?

explore

hotspot

entertainment

leisure time